Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 29, Issue 4, 2010, Pages 410-416

  Golocheikine, Angali ^a   Nath, Dilip S ^a   Ilias Basha, Haseeb ^a   Saini, Deepti ^a   Phelan, Donna ^b   Aloush, Aviva ^a   Trulock, Elbert P ^a   Hachem, Ramsey R ^a   Patterson, G Alexander ^a   Ahearn, Joseph M ^c   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

AMR; complement degradation products; erythrocytes; lung transplantation; self antigens

Indexed keywords

ALLOANTIBODY; ALPHA TUBULIN; AUTOANTIBODY; COLLAGEN TYPE 5; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; METHODOLOGY; PRIORITY JOURNAL; SOLID; STAINING; TISSUE;

ANTIBODIES; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; COLLAGEN TYPE V; COMPLEMENT C3D; COMPLEMENT C4B; ERYTHROCYTES; FEMALE; GRAFT REJECTION; HUMANS; ISOANTIBODIES; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RECEPTORS, COMPLEMENT; TUBULIN;

EID: 77949568820     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.10.003     Document Type: Article

References (30)

1. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665-673
2. Masson E., Stern M., Chabod J., et al. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. J Heart Lung Transplant 26 (2007) 642-645
3. Sundaresan S., Mohanakumar T., Smith M.A., et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65 (1998) 648-653
4. Girnita A.L., McCurry K.R., Iacono A.T., et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 23 (2004) 1135-1141
5. Girnita A.L., Duquesnoy R., Yousem S.A., et al. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant 5 (2005) 131-138
6. Collins A.B., Schneeberger E.E., Pascual M.A., et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 10 (1999) 2208-2214
7. Feucht H.E., Schneeberger H., Hillebrand G., et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 43 (1993) 1333-1338
8. Feucht H.E. Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity. Am J Transplant 3 (2003) 646-652
9. Stewart S., Fishbein M.C., Snell G.I., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26 (2007) 1229-1242
10. Fukami N., Ramachandran S., Saini D., et al. Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 182 (2009) 309-318
11. Bharat A., Fields R.C., Trulock E.P., Patterson G.A., and Mohanakumar T. Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol 177 (2006) 5631-5638
12. Goers T.A., Ramachandran S., Aloush A., Trulock E., Patterson G.A., and Mohanakumar T. De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol 180 (2008) 4487-4494
13. Jaramillo A., Smith M.A., Phelan D., et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 67 (1999) 1155-1161
14. Manzi S., Navratil J.S., Ruffing M.J., et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3596-3604
15. Lee K.C., Chang C.Y., Chuang Y.C., et al. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure. Transplant Proc 40 (2008) 2638-2642
16. Iwata T., Philipovskiy A., Fisher A.J., et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 181 (2008) 5738-5747
17. Westall G.P., Snell G.I., McLean C., Kotsimbos T., Williams T., and Magro C. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant 27 (2008) 722-728
18. Woo M.S. Overview of lung transplantation. Clin Rev Allergy Immunol 35 (2008) 154-163
19. Orens J.B., and Garrity Jr. E.R. General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 6 (2009) 13-19
20. Ng C.Y., Madsen J.C., Rosengard B.R., and Allan J.S. Immunosuppression for lung transplantation. Front Biosci 14 (2009) 1627-1641
21. Allan J.S. Immunosuppression for lung transplantation. Semin Thorac Cardiovasc Surg 16 (2004) 333-341
22. Reinsmoen N.L., Bolman R.M., Savik K., Butters K., and Hertz M.I. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?. Transplantation 55 (1993) 1040-1044
23. Schulman L.L., Ho E.K., Reed E.F., et al. Immunologic monitoring in lung allograft recipients. Transplantation 61 (1996) 252-257
24. Scornik J.C., Zander D.S., Baz M.A., Donnelly W.H., and Staples E.D. Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry. Transplantation 68 (1999) 1542-1546
25. Takemoto S.K., Zeevi A., Feng S., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4 (2004) 1033-1041
26. Diujvestijn A.M., Derhaag J.G., and van Breda Vriesman P.J. Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation. Transpl Int 13 (2000) 363-371
27. Awad M.R., El-Gamel A., Hasleton P., Turner D.M., Sinnott P.J., and Hutchinson I.V. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
28. Morrell M.R., Patterson G.A., Trulock E.P., and Hachem R.R. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 28 (2009) 96-100
29. Magro C.M., Pope Harman A., Klinger D., et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant 3 (2003) 1143-1154
30. Wallace W.D., Reed E.F., Ross D., Lassman C.R., and Fishbein M.C. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study. J Heart Lung Transplant 24 (2005) 1565-1570